Objective: To provide up-to-date European Society of Urogenital Radiology (ESUR) guidelines for staging and follow-up of patients with ovarian cancer (OC).

Methods: Twenty-one experts, members of the female pelvis imaging ESUR subcommittee from 19 institutions, replied to 2 rounds of questionnaires regarding imaging techniques and structured reporting used for pre-treatment evaluation of OC patients. The results of the survey were presented to the other authors during the group's annual meeting. The lexicon was aligned with the Society of American Radiology (SAR)-ESUR lexicon; a first draft was circulated, and then comments and suggestions from the other authors were incorporated.

Results: Evaluation of disease extent at diagnosis should be performed by chest, abdominal, and pelvic CT. The radiological report should map the disease with specific mention of sites that may preclude optimal cytoreductive surgery. For suspected recurrence, CT and [18F]FDG PET-CT are both valid options. MRI can be considered in experienced centres, as an alternative to CT, considering the high costs and the need for higher expertise in reporting.

Conclusions: CT is the imaging modality of choice for preoperative evaluation and follow-up in OC patients. A structured radiological report, including specific mention of sites that may preclude optimal debulking, is of value for patient management.

Key points: Question Guidelines were last published for ovarian cancer (OC) imaging in 2010; here, guidance on imaging techniques and reporting, incorporating advances in the field, are provided. Findings Structured reports should map out sites of disease, highlighting sites that limit cytoreduction. For suspected recurrence, CT and 18FDG PET-CT are options, and MRI can be considered. Clinical relevance Imaging evaluation of OC patients at initial diagnosis (mainly based on CT), using a structured report that considers surgical needs is valuable in treatment selection and planning.

目的：为卵巢癌（OC）患者的分期和随访提供最新的欧洲泌尿生殖放射学会（ESUR）指南。

方法：来自19个机构的女性骨盆造影ESUR小组委员会的21位专家对用于OC患者治疗前评估的影像学技术和结构化报告进行了2轮问卷调查。调查结果在该组织的年会上提交给了其他作者。该词典与美国放射学会（SAR）-ESUR词典保持一致；初稿被传阅，然后其他作者的评论和建议被纳入其中。

结果：诊断时应通过胸部、腹部和盆腔CT评估疾病程度。放射学报告应绘出疾病图，并具体提及可能排除最佳细胞减少手术的部位。对于怀疑复发，CT和[18F]FDG PET-CT都是有效的选择。考虑到高成本和报告需要更高的专业知识，有经验的中心可以考虑MRI作为CT的替代方案。

结论：CT是OC患者术前评估和随访的首选影像学方式。一份结构化的放射报告，包括具体提及可能妨碍最佳减积的部位，对患者管理是有价值的。

重点：卵巢癌（OC）影像学问题指南于2010年发布；这里提供了关于成像技术和报告的指导，并结合了该领域的进展。结构化的报告应绘制出疾病部位，突出限制细胞减少的部位。怀疑复发可选择CT和18FDG PET-CT，也可考虑MRI。临床意义在初次诊断时对OC患者进行影像学评估（主要基于CT），使用考虑手术需求的结构化报告对治疗选择和计划有价值。